Speaker:

Thu Phan

Learning Objectives:

  1. Identify major changes in the 2026 ACC/AHA/Multisociety Dyslipidemia Guideline compared to previous guidelines
  2. Describe the updated approach to ASCVD risk assessment and risk reclassification
  3. Apply updated risk categories, treatment thresholds, and lipid goals to determine appropriate lipid-lowering therapy and treatment goals


Disclosure:
Thu has no relevant financial relationship to disclose.

Session date: 
09/24/2026 - 2:00pm to 3:00pm EDT
  • 1.00 ACPE Pharmacy
  • 1.00 Participation
Please login or register to take this course.